These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 21138175

  • 1. Lymphoma: risk and response after solid organ transplant.
    Jacobson CA, LaCasce AS.
    Oncology (Williston Park); 2010 Sep; 24(10):936-44. PubMed ID: 21138175
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 Sep; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 3. Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.
    Lim WH, Russ GR, Coates PT.
    Nephrology (Carlton); 2006 Aug; 11(4):355-66. PubMed ID: 16889577
    [Abstract] [Full Text] [Related]

  • 4. Lymphoma after solid organ transplantation: risk, response to therapy, and survival at a transplantation center.
    Knight JS, Tsodikov A, Cibrik DM, Ross CW, Kaminski MS, Blayney DW.
    J Clin Oncol; 2009 Jul 10; 27(20):3354-62. PubMed ID: 19451438
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 10; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 6. Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ.
    Transpl Int; 2007 Mar 10; 20(3):207-18. PubMed ID: 17291214
    [Abstract] [Full Text] [Related]

  • 7. New developments in the diagnosis and management of posttransplantation lymphoproliferative disorders in solid organ transplant recipients.
    Preiksaitis JK.
    Clin Infect Dis; 2004 Oct 01; 39(7):1016-23. PubMed ID: 15472855
    [Abstract] [Full Text] [Related]

  • 8. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
    Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J.
    Am J Respir Crit Care Med; 1996 Dec 01; 154(6 Pt 1):1712-7. PubMed ID: 8970360
    [Abstract] [Full Text] [Related]

  • 9. CNS or bone marrow involvement as risk factors for poor survival in post-transplantation lymphoproliferative disorders in children after solid organ transplantation.
    Maecker B, Jack T, Zimmermann M, Abdul-Khaliq H, Burdelski M, Fuchs A, Hoyer P, Koepf S, Kraemer U, Laube GF, Müller-Wiefel DE, Netz H, Pohl M, Toenshoff B, Wagner HJ, Wallot M, Welte K, Melter M, Offner G, Klein C.
    J Clin Oncol; 2007 Nov 01; 25(31):4902-8. PubMed ID: 17971586
    [Abstract] [Full Text] [Related]

  • 10. Identifying the patient at risk for post-transplant lymphoproliferative disorder.
    Cockfield SM.
    Transpl Infect Dis; 2001 Jun 01; 3(2):70-8. PubMed ID: 11395972
    [Abstract] [Full Text] [Related]

  • 11. Posttransplant lymphoproliferative disorder.
    Everly MJ, Bloom RD, Tsai DE, Trofe J.
    Ann Pharmacother; 2007 Nov 01; 41(11):1850-8. PubMed ID: 17940127
    [Abstract] [Full Text] [Related]

  • 12. Post-transplant lymphoproliferative disorders following solid-organ transplantation.
    Blaes AH, Morrison VA.
    Expert Rev Hematol; 2010 Feb 01; 3(1):35-44. PubMed ID: 21082932
    [Abstract] [Full Text] [Related]

  • 13. Managing the challenge of PTLD in liver and bowel transplant recipients.
    Lauro A, Arpinati M, Pinna AD.
    Br J Haematol; 2015 Apr 01; 169(2):157-72. PubMed ID: 25377273
    [Abstract] [Full Text] [Related]

  • 14. Post-transplant lymphoproliferative disorders. Molecular analysis of histogenesis and pathogenesis.
    Capello D, Berra E, Cerri M, Gaidano G.
    Minerva Med; 2004 Feb 01; 95(1):53-64. PubMed ID: 15041926
    [Abstract] [Full Text] [Related]

  • 15. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep 01; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 16. Early evidence of lymphoproliferative disorder: post-transplant monitoring of Epstein-Barr infection in adult and pediatric patients.
    Gaeta A, Nazzari C, Verzaro S, Latte MC, Fabri G, Scateni S, Raggi C, Lubrano R, Mancini C.
    New Microbiol; 2006 Oct 01; 29(4):231-41. PubMed ID: 17201089
    [Abstract] [Full Text] [Related]

  • 17. Management of post-transplant lymphoproliferative disorders.
    DeStefano CB, Desai SH, Shenoy AG, Catlett JP.
    Br J Haematol; 2018 Aug 01; 182(3):330-343. PubMed ID: 29741774
    [Abstract] [Full Text] [Related]

  • 18. Plasmablastic posttransplant lymphoma: cytogenetic aberrations and lack of Epstein-Barr virus association linked with poor outcome in the prospective German Posttransplant Lymphoproliferative Disorder Registry.
    Zimmermann H, Oschlies I, Fink S, Pott C, Neumayer HH, Lehmkuhl H, Hauser IA, Dreyling M, Kneba M, Gärtner B, Anagnostopoulos I, Riess H, Klapper W, Trappe RU.
    Transplantation; 2012 Mar 15; 93(5):543-50. PubMed ID: 22234349
    [Abstract] [Full Text] [Related]

  • 19. Clinicopathologic characteristics of post-transplant lymphoproliferative disorders.
    Nalesnik MA.
    Recent Results Cancer Res; 2002 Mar 15; 159():9-18. PubMed ID: 11785849
    [Abstract] [Full Text] [Related]

  • 20. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL.
    Clin Transplant; 2012 Mar 15; 26(5):679-83. PubMed ID: 22324300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.